01 January 2005
Minocycline-induced hepatitis with autoimmune features
Shusuke Morizono, Munechika Enjoji, Shinichiro Takao, Eiichiro Arimura, Motoyuki Kohjima, Yuzuru Miyagi, Tsuyosi Yoshimoto, Kazuhiro Kotoh, Makoto NakamutaCase Rep Clin Pract Rev 2005; 6:144-147 :: ID: 428842
Abstract
Background: Prolonged treatment with minocycline for acne vulgaris has been reported to induce the development of autoimmune phenomena.Case Report: An adolescent male presented with active hepatitis after taking long term minocycline for acne vulgaris. The patient was jaundiced and experienced profound malaise. He had severe hepatitis with an alanine aminotransferase concentration of 876 IU/L, a total bilirubin concentration of 27.8 mg/dL, a prolonged prothrombin time of 20%, and a strongly positive antinuclear antibody titer. Hepatitis viral screens and other autoantibody tests gave negative results. Liver biopsy showed moderately severe chronic active hepatitis. Although liver transplantation was considered, the patient symptoms resolved upon treatment with corticosteroids in addition to discontinuation of minocycline, and remission was achieved. The patient has had no recurrence of symptoms or biochemical abnormalities after the withdrawal of corticosteroids, emphasizing that these reactions were likely due to minocycline-related autoimmune hepatitis.Conclusions: Liver function should be carefully monitored in patients who receive prolonged minocycline therapy, and minocycline-induced hepatitis should be recognized at an early stage. Because this form of hepatitis tends to resolve slowly following cessation of minocycline, treatment with corticosteroids should also be considered to fasten recovery.
Keywords: Minocycline, autoimmune hepatitis, corticosteroid
SARS-CoV-2/COVID-19
29 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936896
16 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936498
13 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936889
13 June 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936128
In Press
01 Jul 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936536
30 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937061
30 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936896
30 Jun 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936967
Most Viewed Current Articles
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
09 Feb 2022 : Case report
DOI :10.12659/AJCR.934744
Am J Case Rep 2022; 23:e934744